This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffeic (1), rosmarinic (2), chlorogenic (3), and cryptochlorogenic (4), acids and isoverbascoside (5). All compounds inhibited Leishmania amazonensis arginase with IC50—in range of 1.5—11 μM. Compounds 2 and 5 also showed activity against promastigotes of L. amazonensis with IC50 = 61 (28–133) μM and IC50 = 14 (9–24) μM, respectively. Further computational studies applying molecular docking simulations were performed on the competitive inhibitors to gain insight into the molecular basis for arginase inhibition and could be exploited to the development of new antileishmanials drug targeting parasite arginase.

da Silva, E.R., Brogi, S., Grillo, A., Campiani, G., Gemma, S., Vieira, P.C., et al. (2019). Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase. CHEMICAL BIOLOGY & DRUG DESIGN, 93(2), 139-146 [10.1111/cbdd.13391].

Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase

Brogi, Simone;Grillo, Alessandro;Campiani, Giuseppe;Gemma, Sandra;
2019-01-01

Abstract

This study describes the activity of five natural hydroxycinnamic acids and derived compound: caffeic (1), rosmarinic (2), chlorogenic (3), and cryptochlorogenic (4), acids and isoverbascoside (5). All compounds inhibited Leishmania amazonensis arginase with IC50—in range of 1.5—11 μM. Compounds 2 and 5 also showed activity against promastigotes of L. amazonensis with IC50 = 61 (28–133) μM and IC50 = 14 (9–24) μM, respectively. Further computational studies applying molecular docking simulations were performed on the competitive inhibitors to gain insight into the molecular basis for arginase inhibition and could be exploited to the development of new antileishmanials drug targeting parasite arginase.
da Silva, E.R., Brogi, S., Grillo, A., Campiani, G., Gemma, S., Vieira, P.C., et al. (2019). Cinnamic acids derived compounds with antileishmanial activity target Leishmania amazonensis arginase. CHEMICAL BIOLOGY & DRUG DESIGN, 93(2), 139-146 [10.1111/cbdd.13391].
File in questo prodotto:
File Dimensione Formato  
Silva_et_al-2019-Chemical_Biology_&_Drug_Design.pdf

non disponibili

Tipologia: PDF editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 1.2 MB
Formato Adobe PDF
1.2 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1067837